U.K. Artificial Intelligence In Precision Medicine Market Size & Outlook
- Healthcare IT
- AI in Healthcare
- artificial intelligence precision medicine market report
- AI in Healthcare
Global Market
Related Markets
Ask Prism AI about the artificial intelligence precision medicine market report market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
UK artificial intelligence in precision medicine market highlights
- The UK artificial intelligence in precision medicine market generated a revenue of USD 148.4 million in 2025 and is expected to reach USD 2,072.1 million by 2033.
- The UK market is expected to grow at a CAGR of 39% from 2026 to 2033.
- In terms of segment, deep learning was the largest revenue generating technology in 2025.
- Natural language processing is the most lucrative technology segment registering the fastest growth during the forecast period.
Artificial intelligence in precision medicine market data book summary
| Market revenue in 2025 | USD 148.4 million |
| Market revenue in 2033 | USD 2,072.1 million |
| Growth rate | 39% (CAGR from 2026 to 2033) |
| Largest segment | Deep learning |
| Fastest growing segment | Natural language processing |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
| Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
Other key industry trends
- In terms of revenue, UK accounted for 6.1% of the global artificial intelligence in precision medicine market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK artificial intelligence in precision medicine market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 2,072.1 million by 2033.
The rising incidence of rare diseases is expected to accelerate the market expansion in the country. The development of several therapeutic activities and individualized medical treatments has been made possible by advancements in our understanding and correlation of the properties of the human genome.
In February 2020, Benevolent AI, an AI startup based in the UK, published two studies, one in The Lancet and one in The Lancet Infectious Diseases, identifying authorized medications that might obstruct the SARS-CoV-2 virus's ability to replicate.
The company's AI system found six drugs that successfully block a cellular route that let the virus enter cells to replicate new virus particles using a massive collection of medical data, including data gathered from the scientific literature by ML.
No credit card required*
Publish Date: Sep 04, 2024
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence Precision Medicine Market Report
Artificial Intelligence Precision Medicine Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Intel Corp | View profile | 124,800 | 2200 Mission College Boulevard, Santa Clara, CA, United States, 95054-1549 | www.intel.com |
| International Business Machines Corp | View profile | 282,200 | One New Orchard Road, Armonk, NY, United States, 10504 | www.ibm.com |
| Microsoft Corp | View profile | 221,000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | www.microsoft.com |
| NVIDIA Corp | View profile | 29,600 | 2788 San Tomas Expressway, Santa Clara, CA, United States, 95051 | www.nvidia.com |
| Alphabet Inc Class A | View profile | 180,895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | www.abc.xyz |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| BioXcel Therapeutics Inc | View profile | 74 | 555 Long Wharf Drive, New Haven, CT, United States, 06511 | www.bioxceltherapeutics.com |
| Enlitic | View profile | 51-100 | San Francisco, California, United States, North America | www.enlitic.com/ |
U.K. artificial intelligence precision medicine market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Precision Medicine Market Outlook will help companies and investors design strategic landscapes.
Deep Learning was the largest segment with a revenue share of 46.77% in 2025.
Horizon Databook has segmented the U.K. artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2021 to 2033.
The rising incidence of rare diseases is expected to accelerate the market expansion in the country. The development of several therapeutic activities and individualized medical treatments has been made possible by advancements in our understanding and correlation of the properties of the human genome.
In February 2020, Benevolent AI, an AI startup based in the UK, published two studies, one in The Lancet and one in The Lancet Infectious Diseases, identifying authorized medications that might obstruct the SARS-CoV-2 virus's ability to replicate.
The company's AI system found six drugs that successfully block a cellular route that let the virus enter cells to replicate new virus particles using a massive collection of medical data, including data gathered from the scientific literature by ML.
- U.K. Artificial Intelligence In Precision Medicine Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Deep Learning
- Querying Method
- Natural language processing
- Context aware processing
- U.K. Artificial Intelligence In Precision Medicine Market Component Outlook (Revenue, USD Million , 2021-2033)
- Hardware
- Software
- Service
- U.K. Artificial Intelligence In Precision Medicine Market Therapeutic Application Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Cardiology
- Neurology
- Respiratory
- Others
Reasons to subscribe to artificial intelligence precision medicine market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of artificial intelligence precision medicine market report databook
- Our clientele includes a mix of artificial intelligence precision medicine market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. artificial intelligence precision medicine market report, including forecasts for subscribers. This country databook contains high-level insights into U.K. artificial intelligence precision medicine market report from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.K. Artificial Intelligence In Precision Medicine Market, 2021-2033 (US$M)
UK artificial intelligence precision medicine market report statistics, by technology, 2021-2033 (US$M)
